Nothing Special   »   [go: up one dir, main page]
Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Adenosine A2A receptor mediates microglial process retraction

Nature Neuroscience volume 12, pages 872–878 (2009)Cite this article

Abstract

Cell motility drives many biological processes, including immune responses and embryonic development. In the brain, microglia are immune cells that survey and scavenge brain tissue using elaborate and motile cell processes. The motility of these processes is guided by the local release of chemoattractants. However, most microglial processes retract during prolonged brain injury or disease. This hallmark of brain inflammation remains unexplained. We identified a molecular pathway in mouse and human microglia that converted ATP-driven process extension into process retraction during inflammation. This chemotactic reversal was driven by upregulation of the A2A adenosine receptor coincident with P2Y12 downregulation. Thus, A2A receptor stimulation by adenosine, a breakdown product of extracellular ATP, caused activated microglia to assume their characteristic amoeboid morphology during brain inflammation. Our results indicate that purine nucleotides provide an opportunity for context-dependent shifts in receptor signaling. Thus, we reveal an unexpected chemotactic switch that generates a hallmark feature of CNS inflammation.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Microglial activation in vitro.
Figure 2: ATP induces migratory repulsion in activated microglia.
Figure 3: ATP induces process retraction and slowed motility in activated microglia.
Figure 4: Gs-coupled signaling mediates microglial repulsion from ATP.
Figure 5: Adenosine A2A receptor upregulation mediates process retraction in activated microglia.
Figure 6: Human microglia show a similar shift in purinergic receptor expression and chemotactic response to ATP.
Figure 7: A2A receptor upregulation and involvement in microglial retraction in vivo.
Figure 8: A2A stimulation inhibits uptake by LPS-treated microglia.

Similar content being viewed by others

References

  1. Hanisch, U.K. & Kettenmann, H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10, 1387–1394 (2007).

    Article  CAS  PubMed  Google Scholar 

  2. Kreutzberg, G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19, 312–318 (1996).

    Article  CAS  PubMed  Google Scholar 

  3. Nimmerjahn, A., Kirchhoff, F. & Helmchen, F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314–1318 (2005).

    CAS  PubMed  Google Scholar 

  4. Davalos, D. et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 8, 752–758 (2005).

    CAS  PubMed  Google Scholar 

  5. Haynes, S.E. et al. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat. Neurosci. 9, 1512–1519 (2006).

    CAS  PubMed  Google Scholar 

  6. Stence, N., Waite, M. & Dailey, M.E. Dynamics of microglial activation: a confocal time-lapse analysis in hippocampal slices. Glia 33, 256–266 (2001).

    Article  CAS  PubMed  Google Scholar 

  7. Block, M.L., Zecca, L. & Hong, J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8, 57–69 (2007).

    Article  CAS  PubMed  Google Scholar 

  8. Jakob, A. Handbuch der Psychiatrie 1 (Aschaffenburg, G.) 268 (Deuticke, Vienna, 1927).

    Google Scholar 

  9. Nasu-Tada, K., Koizumi, S. & Inoue, K. Involvement of β1 integrin in microglial chemotaxis and proliferation on fibronectin: different regulations by ADP through PKA. Glia 52, 98–107 (2005).

    Article  PubMed  Google Scholar 

  10. Honda, S. et al. Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors. J. Neurosci. 21, 1975–1982 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Wang, C.X. & Shuaib, A. Involvement of inflammatory cytokines in central nervous system injury. Prog. Neurobiol. 67, 161–172 (2002).

    Article  CAS  PubMed  Google Scholar 

  12. Nolte, C., Moller, T., Walter, T. & Kettenmann, H. Complement 5a controls motility of murine microglial cells in vitro via activation of an inhibitory G protein and the rearrangement of the actin cytoskeleton. Neuroscience 73, 1091–1107 (1996).

    Article  CAS  PubMed  Google Scholar 

  13. Möller, T., Kann, O., Verkhratsky, A. & Kettenmann, H. Activation of mouse microglial cells affects P2 receptor signaling. Brain Res. 853, 49–59 (2000).

    Article  PubMed  Google Scholar 

  14. Burridge, K. & Wennerberg, K. Rho and Rac take center stage. Cell 116, 167–179 (2004).

    Article  CAS  PubMed  Google Scholar 

  15. Mitchison, T.J. & Cramer, L.P. Actin-based cell motility and cell locomotion. Cell 84, 371–379 (1996).

    Article  CAS  PubMed  Google Scholar 

  16. Nagasawa, S.Y., Takuwa, N., Sugimoto, N., Mabuchi, H. & Takuwa, Y. Inhibition of Rac activation as a mechanism for regulation of actin cytoskeletal reorganization and cell motility by cAMP. Biochem. J. 385, 737–744 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Hashmi, A.Z. et al. Adenosine inhibits cytosolic calcium signals and chemotaxis in hepatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G395–G401 (2007).

    Article  CAS  PubMed  Google Scholar 

  18. Fredholm, B.B., IJzerman, A.P., Jacobson, K.A., Klotz, K.N. & Linden, J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53, 527–552 (2001).

    CAS  PubMed  Google Scholar 

  19. Ongini, E. & Fredholm, B.B. Pharmacology of adenosine A2A receptors. Trends Pharmacol. Sci. 17, 364–372 (1996).

    Article  CAS  PubMed  Google Scholar 

  20. Wittendorp, M.C. & Boddeke, H.W.G.M. & Biber, K. Adenosine A3 receptor–induced CCL2 synthesis in cultured mouse astrocytes. Glia 46, 410–418 (2004).

    Article  PubMed  Google Scholar 

  21. Angulo, E. et al. A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer's disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation. Brain Pathol. 13, 440–451 (2003).

    Article  CAS  PubMed  Google Scholar 

  22. Murphree, L.J., Sullivan, G.W., Marshall, M.A. & Linden, J. Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-kappaB in A(2A) adenosine receptor induction. Biochem. J. 391, 575–580 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Braun, N., Lenz, C., Gillardon, F., Zimmermann, M. & Zimmermann, H. Focal cerebral ischemia enhances glial expression of ecto-5′-nucleotidase. Brain Res. 766, 213–226 (1997).

    Article  CAS  PubMed  Google Scholar 

  24. Braun, N. et al. Assignment of ecto-nucleoside triphosphate diphosphohydrolase-1/cd39 expression to microglia and vasculature of the brain. Eur. J. Neurosci. 12, 4357–4366 (2000).

    CAS  PubMed  Google Scholar 

  25. Schoen, S.W., Graeber, M.B. & Kreutzberg, G.W. 5′-Nucleotidase immunoreactivity of perineural microglia responding to rat facial nerve axotomy. Glia 6, 314–317 (1992).

    Article  CAS  PubMed  Google Scholar 

  26. Färber, K. et al. The ectonucleotidase cd39/ENTPDase1 modulates purinergic-mediated microglial migration. Glia 56, 331–341 (2008).

    Article  PubMed  Google Scholar 

  27. Rodríguez-Núñez, A. et al. Concentrations of nucleotides, nucleosides, purine bases, oxypurines, uric acid, and neuron-specific enolase in the cerebrospinal fluid of children with sepsis. J. Child Neurol. 16, 704–706 (2001).

    Article  PubMed  Google Scholar 

  28. Guthrie, P.B. et al. ATP released from astrocytes mediates glial calcium waves. J. Neurosci. 19, 520–528 (1999).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Koizumi, S., Fujishita, K., Tsuda, M., Shigemoto-Mogami, Y. & Inoue, K. Dynamic inhibition of excitatory synaptic transmission by astrocyte-derived ATP in hippocampal cultures. Proc. Natl. Acad. Sci. USA 100, 11023–11028 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Verderio, C. & Matteoli, M. ATP mediates calcium signaling between astrocytes and microglial cells: modulation by IFN-gamma. J. Immunol. 166, 6383–6391 (2001).

    Article  CAS  PubMed  Google Scholar 

  31. Pedata, F., Corsi, C., Melani, A., Bordoni, F. & Latini, S. Adenosine extracellular brain concentrations and role of A2A receptors in ischemia. Ann. NY Acad. Sci. 939, 74–84 (2001).

    Article  CAS  PubMed  Google Scholar 

  32. Tomozawa, Y., Yabuuchi, K., Inoue, T. & Satoh, M. Participation of cAMP and cAMP-dependent protein kinase in beta-adrenoceptor–mediated interleukin-1 beta mRNA induction in cultured microglia. Neurosci. Res. 22, 399–409 (1995).

    Article  CAS  PubMed  Google Scholar 

  33. Zhang, B. et al. Suppressive effects of phosphodiesterase type IV inhibitors on rat cultured microglial cells: comparison with other types of cAMP-elevating agents. Neuropharmacology 42, 262–269 (2002).

    Article  CAS  PubMed  Google Scholar 

  34. Min, K.J., Yang, M.S., Jou, I. & Joe, E.H. Protein kinase A mediates microglial activation induced by plasminogen and gangliosides. Exp. Mol. Med. 36, 461–467 (2004).

    Article  CAS  PubMed  Google Scholar 

  35. Schwarzschild, M.A., Agnati, L., Fuxe, K., Chen, J.F. & Morelli, M. Targeting adenosine A2A receptors in Parkinson's disease. Trends Neurosci. 29, 647–654 (2006).

    Article  CAS  PubMed  Google Scholar 

  36. Xu, K., Bastia, E. & Schwarzschild, M. Therapeutic potential of adenosine A(2A) receptor antagonism in Parkinson's disease. Pharmacol. Ther. 105, 267–310 (2005).

    Article  CAS  PubMed  Google Scholar 

  37. Popoli, P. et al. Functions, dysfunctions and possible therapeutic relevance of adenosine A2A receptors in Huntington's disease. Prog. Neurobiol. 81, 331–348 (2007).

    Article  CAS  PubMed  Google Scholar 

  38. Fiebich, B.L. et al. Cyclooxygenase 2 expression in rat microglia is induced by adenosine A2a receptors. Glia 18, 152–160 (1996).

    Article  CAS  PubMed  Google Scholar 

  39. Heese, K., Fiebich, B.L., Bauer, J. & Otten, U. Nerve growth factor (NGF) expression in rat microglia is induced by adenosine A2a receptors. Neurosci. Lett. 231, 83–86 (1997).

    Article  CAS  PubMed  Google Scholar 

  40. Küst, B.M., Biber, K., van Calker, D. & Gebicke-Haerter, P.J. Regulation of K+ channel mRNA expression by stimulation of adenosine A2a receptors in cultured rat microglia. Glia 25, 120–130 (1999).

    Article  PubMed  Google Scholar 

  41. Klegeris, A., Bissonnette, C.J. & McGeer, P.L. Modulation of human microglia and THP-1 cell toxicity by cytokines endogenous to the nervous system. Neurobiol. Aging 26, 673–682 (2005).

    Article  CAS  PubMed  Google Scholar 

  42. Bystrova, M.F., Yatzenko, Y.E., Fedorov, I.V., Rogachevskaja, O.A. & Kolesnikov, S.S. P2Y isoforms operative inmouse taste cells. Cell Tissue Res. 323, 377–382 (2006).

    Article  CAS  PubMed  Google Scholar 

  43. Bianco, F. et al. Pathophysiological roles of extracellular nucleotides in glial cells: differential expression of purinergic receptors in resting and activated microglia. Brain Res. Brain Res. Rev. 48, 144–156 (2005).

    Article  CAS  PubMed  Google Scholar 

  44. Hoskin, D.W., Butler, J.J., Drapeau, D., Haeryfar, S.M. & Blay, J. Adenosine acts through an A3 receptor to prevent the induction of murine anti-CD3–activated killer T cells. Int. J. Cancer 99, 386–395 (2002).

    Article  CAS  PubMed  Google Scholar 

  45. Grijelmo, C. et al. Proinvasive activity of BMP-7 through SMAD4/src-independent and ERK/Rac/JNK-dependent signaling pathways in colon cancer cells. Cell. Signal. 19, 1722–1732 (2007).

    Article  CAS  PubMed  Google Scholar 

  46. Chen, Y., Shukla, A., Namiki, S., Insel, P.A. & Junger, W.G. A putative osmoreceptor system that controls neutrophil function through the release of ATP, its conversion to adenosine, and activation of A2 adenosine and P2 receptors. J. Leukoc. Biol. 76, 245–253 (2004).

    Article  CAS  PubMed  Google Scholar 

  47. Feng, C., Mery, A.G., Beller, E.M., Favot, C. & Boyce, J.A. Adenine nucleotides inhibit cytokine generation by human mast cells through a Gs-coupled receptor. J. Immunol. 173, 7539–7547 (2004).

    Article  CAS  PubMed  Google Scholar 

  48. Kyrkanides, S. et al. Cyclooxygenase-2 modulates brain inflammation-related gene expression in central nervous system radiation injury. Brain Res. Mol. Brain Res. 104, 159–169 (2002).

    Article  CAS  PubMed  Google Scholar 

  49. Tha, K.K. et al. Changes in expression of proinflammatory cytokines IL-1beta, TNF-alpha and IL-6 in the brain of senescence accelerated mouse (SAM) P8. Brain Res. 885, 25–31 (2000).

    Article  CAS  PubMed  Google Scholar 

  50. Park, J.S., Woo, M.S., Kim, S.Y., Kim, W.K. & Kim, H.S. Repression of interferon-gamma-induced inducible nitric oxide synthase (iNOS) gene expression in microglia by sodium butyrate is mediated through specific inhibition of ERK signaling pathways. J. Neuroimmunol. 168, 56–64 (2005).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank B.D. Shur, R. Dingledine and J.M. Boss for discussions on the manuscript, J. Olson for assistance in the studies of human microglia, and E.R. Weeks and D. Semwogerere in the Emory University Department of Physics for useful discussions of image analysis techniques. We are also grateful to K.M. Vellano, A.G. Almonte and J.B. Revennaugh for excellent technical assistance with cell cultures, imaging equipment and animal maintenance. This work was supported by a US National Institutes of Health National Research Service Award fellowship to A.G.O., a pilot grant from the US National Institutes of Health (P01 ES016731), the National Parkinson's Foundation (S.F.T.) and US National Institutes of Health funding for S.F.T.

Author information

Authors and Affiliations

  1. Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia, USA

    Anna G Orr & Stephen F Traynelis

  2. Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USA

    Adam L Orr & Xiao-Jiang Li

  3. Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia, USA

    Robert E Gross

Authors
  1. Anna G Orr
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adam L Orr
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiao-Jiang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Robert E Gross
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stephen F Traynelis
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

A.G.O. designed and carried out the study, collected and analyzed data, and wrote the paper. A.L.O. helped carry out in vivo experiments, brain tissue processing and manuscript revisions. X.-J.L. provided surgical equipment and immunohistochemical reagents, R.E.G. provided human tissue samples and helped with experimental design and interpretation, and S.F.T. was involved in study design, interpretation of data and revision of the manuscript and figures.

Corresponding authors

Correspondence to Anna G Orr or Stephen F Traynelis.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–6 (PDF 675 kb)

Supplementary Video 1

ATP repels LPS-treated microglia. Time-lapse three-dimensional reconstruction of a cultured LPS-activated mouse microglia migrating away from an ATP-filled micropipette positioned just beyond right edge of screen (pipette not shown). (MOV 1378 kb)

Supplementary Video 2

ATP induces process extension in untreated microglia. Time-lapse three-dimensional reconstruction of a mouse microglia exhibiting process extension toward the periphery of field during bath application of ATP. (MOV 1448 kb)

Supplementary Video 3

ATP induces process retraction in LPS-treated microglia. Time-lapse three-dimensional reconstruction of an LPS-activated mouse microglia exhibiting process retraction during bath application of ATP. (MOV 1371 kb)

Supplementary Video 4

ATP inhibits microglial process motion. Three-dimensional tracking (red traces) of cell processes of an LPS-activated mouse microglia. Bath application of ATP inhibited process motility. (MOV 1037 kb)

Supplementary Video 5

ATP attracts untreated human microglia. Cultured human microglia migrated toward and engulfed an ATP-filled micropipette at right. (MOV 5096 kb)

Supplementary Video 6

ATP repels LPS-treated human microglia. Cultured LPS-activated human microglia migrated away from an ATP-filled micropipette at right (pipette chases cell across field). (MOV 5700 kb)

Supplementary Video 7

Acute injury attracts untreated microglia in vitro. Untreated GFP-positive mouse microglia extended their processes toward acutely injured astrocytes. Mechanical injury (right edge) was induced with a micropipette at approximately 9 min (n = 3). (MOV 1323 kb)

Supplementary Video 8

Acute injury repels LPS-treated microglia in vitro. LPS-activated GFP-positive mouse microglia retracted its processes following astrocyte injury. Mechanical injury (right edge) was induced with a micropipette at approximately 8 min (n = 6). (MOV 1139 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Orr, A., Orr, A., Li, XJ. et al. Adenosine A2A receptor mediates microglial process retraction. Nat Neurosci 12, 872–878 (2009). https://doi.org/10.1038/nn.2341

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nn.2341

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing